"Despite the expansion of the 340B program, less than half of the claims prescribed by 340B-affiliated clinicians are captured by 340B pharmacies."

"2013 to 2020 Medicare Part D claims data, the proportion of 340B claims increased from 1.7% in 2013 to 9.6% in 2020."

-A significant amount of potential loss/risk to Phrma if all claims were captured, even before the finding in the Genesis lawsuit. (It found that the entity was not required to issue the script for their -under an undefined time period and sequence of service and script- patient.)

-340B takes precedence over the government for MFP claims, so IRA savings could shift by 2x from the Medicare program to 340B entities.